Heritage Group

Portfolio · 3

Biond Biologics

Immunotherapies for Cancer and Auto-immune Diseases

1 round $15.0M committed Latest: 2021-11

CyCognito

Attack Surface Analysis and Remediation Platform

1 round $100.0M committed Latest: 2021-11

Simplee

Financial Engagement Software

2 rounds $30.0M committed Latest: 2016-05

Investment activity

1 portfolio exit on record.

Q&A

What is Heritage Group's sector focus based on its portfolio companies?

Heritage Group shows a concentration in Health Tech & Life Sciences and Cyber Security, with two portfolio companies in the former and one in the latter.

Can you name a notable exit for Heritage Group?

Heritage Group saw an exit in February 2020 with the acquisition of Simplee by Flywire. Simplee had raised $37.8M prior to its acquisition.

Which portfolio companies has Heritage Group invested in recently?

Heritage Group has recently invested in Valera Health, a comprehensive behavioral health solution, and CyCognito, an attack surface analysis and remediation platform.

What is Heritage Group's investment stage preference?

Heritage Group has participated in various stages, including Series C rounds for Biond Biologics and CyCognito, and a Series A round for Valera Health.

What is Heritage Group's investment activity in the Health Tech & Life Sciences sector?

Heritage Group has two portfolio companies in the Health Tech & Life Sciences sector: Biond Biologics, which develops immunotherapies, and Valera Health, a behavioral health solution.

When did Heritage Group make its most recent investments?

Heritage Group made investments in November 2021 and October 2022, with two investments in 2021 and one in 2022.

What is the total amount raised by CyCognito, a Heritage Group portfolio company?

CyCognito, a portfolio company of Heritage Group, has raised $153M.

What is the total amount raised by Biond Biologics, a Heritage Group portfolio company?

Biond Biologics, a portfolio company of Heritage Group, has raised $37M.